iSpecimen 

$0.8255
41
+$0.03+4.19%Friday 19:59
+$0.00+0.42%Friday 23:50After hours

Statistics

Day High
0.8255
Day Low
0.8147
52W High
32.96
52W Low
0.753
Volume
991
Avg. Volume
-
Mkt Cap
2.08M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Nov 2Expected
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-152
-102.03
-52.07
-2.1
Expected EPS
N/A
Actual EPS
N/A

Financials

-543.7%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
1.93MRevenue
-10.49MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ISPC. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Thermo Fisher Scientific
TMO
Mkt Cap242.11B
Thermo Fisher Scientific offers a broad range of services and products for scientific research and healthcare, including specimen collection and processing, directly competing with iSpecimen's core services.
Bio-Rad Laboratories
BIO
Mkt Cap9.87B
Bio-Rad Laboratories provides a variety of products and services for life science research and clinical diagnostics, competing in the specimen collection and analysis market.
Mettler-Toledo International
MTD
Mkt Cap29.78B
Mettler-Toledo International is involved in precision instruments and services for professional use, including laboratory equipment that can be used in specimen analysis, overlapping with iSpecimen's market.
Agilent Technologies
A
Mkt Cap47.3B
Agilent Technologies provides instruments, services, consumables, applications, and expertise for laboratory workflow, including specimen analysis, making it a competitor.
Quest Diagnostics
DGX
Mkt Cap25.75B
Quest Diagnostics offers diagnostic testing services, including specimen collection and processing, directly competing with iSpecimen's services.
Labcorp
LH
Mkt Cap22.7B
Laboratory Corporation of America Holdings operates as a life sciences company and a direct competitor in clinical laboratory and end-to-end drug development services.
Bruker
BRKR
Mkt Cap9.64B
Bruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions that can be used in specimen analysis, competing with iSpecimen.
Waters
WAT
Mkt Cap41.78B
Waters Corporation produces analytical standards and reagents, chromatography columns, and sample preparation products, which are used in specimen analysis, making it a competitor.
Guardant Health
GH
Mkt Cap23.86B
Guardant Health focuses on liquid biopsies and cancer diagnostics, competing in the niche of specimen analysis for healthcare research and diagnostics, similar to iSpecimen's market focus.

About

iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from the Americas. The Company has one reportable segment: biospecimens.
Show More
CEO
Shahin Behroyan
Employees
7
Country
United States
ISIN
US45032V3069

Listings

0 Comments

Share your thoughts

FAQs

What is iSpecimen stock price today?▼
The current price of ISPC is $0.83 USD — it has increased by +4.19% in the past 24 hours. Watch iSpecimen stock price performance more closely on the chart.
What is iSpecimen stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange iSpecimen stocks are traded under the ticker ISPC.
Is iSpecimen stock price growing?▼
ISPC stock has fallen by -1.7% compared to the previous week, the month change is a -23.56% fall, over the last year iSpecimen has showed a -97.35% decrease.
What is iSpecimen market cap?▼
Today iSpecimen has the market capitalization of 2.08M
When is the next iSpecimen earnings date?▼
iSpecimen is going to release the next earnings report on March 17, 2027.
What is iSpecimen revenue for the last year?▼
iSpecimen revenue for the last year amounts to 1.93M USD.
What is iSpecimen net income for the last year?▼
ISPC net income for the last year is -10.49M USD.
How many employees does iSpecimen have?▼
As of November 2, 2026, the company has 7 employees.
In which sector is iSpecimen located?▼
iSpecimen operates in the Health & Wellness sector.
When did iSpecimen complete a stock split?▼
The last stock split for iSpecimen was on April 28, 2026 with a ratio of 1:40.
Where is iSpecimen headquartered?▼
iSpecimen is headquartered in WOBURN, United States.